Antibody Discovery News and Research

RSS
Vaccinex antibody licensed to GlaxoSmithKline

Vaccinex antibody licensed to GlaxoSmithKline

Morphotek announces agreement for development of antibodies to treat prostate cancer

Morphotek announces agreement for development of antibodies to treat prostate cancer

Vaccinex receives new European patent for antibody discovery technology

Vaccinex receives new European patent for antibody discovery technology

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Pfizer acquires antibody discovery company Bioren

Pfizer acquires antibody discovery company Bioren

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.